AstraZeneca's push into CAR-T therapies for cancer has continued with an agreement to take full control of C-CAR031, an anti-GPC3 therapy for solid tumours, from AbelZeta. In the latest development, ...

Want a gift they’ll love this year under $100? These unique gift ideas will put a smile on their faces!